MIRA
INFORM REPORT
|
Report Date : |
20.06.2007 |
IDENTIFICATION DETAILS
|
Name : |
PFIZER (PTY) LTD. |
|
|
|
|
Registered Office : |
1 Eastern Point
Road, |
|
|
|
|
Country : |
|
|
|
|
|
Line of Business : |
Pharmaceutical and
Medicine Manufacturing |
RATING & COMMENTS
|
MIRA’s Rating : |
NR |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
NR |
In view of the lack of information, we have no basis upon which to
recommend credit dealings |
No Rating |
|
Status : |
Undetermined |
IDENTIFICATION &
EXECUTIVE SUMMARY
Company Name: PFIZER
(PTY) LTD.
Address: 1
EASTERN POINT ROAD
City:
State/Province:
Zip Code:
Country: UNITED
STATES
Telephone: 860
715-4218
Facsimile: 860
441-8739
As of:
Sales / Revenue:
Net Income:
Total Equity:
Legal Form:
Website: www.pfizer.com.au
Business Activity:
NOTE TO CLIENT
Amount Requested: 500,000
The amounts
requested and advised are expressed in:
ZAR
IMPERATIVES
The provided Firm;
PFIZER (PTY) LTD. is not registered in The United States. PFIZER (PTY) LTD. the
Australian parent company of its
The provided
address; 1 Eastern Point Road, Groton, CT 06320 is owned by PFIZER (PTY) LTD.,
however it has no presence in the building which is occupied by the Firm's
subsidiary; PFIZER INC.
The following was
provided by PFIZER (PTY) LTD. web address: " With a history dating back to
1886, Pfizer
We employ more than
1500 staff and annual exports from our three manufacturing plants have an
Australian market value in excess of AU $100 million.
Pfizer
DUE TO THE
INFORMATION IS THIS REPORT
No public or payment
history could be obtained.
This is a full
investigation.
LEGAL
Legal Form:
Previous Legal Form:
Company is NOT
required to publish an annual financial report.
FINANCIAL INFORMATION
Financial figures
and expenditures are presented above.
CURRENT OPERATIONS
NAICS Code: 32541
Pharmaceutical and Medicine Manufacturing
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit
consideration. Capability to overcome financial difficulties seems
comparatively below average/normal. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
NR |
In view of the lack of information, we have no basis upon which to
recommend credit dealings |
No Rating |
|
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)